Publicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (34)

2024

  1. Respiratory syncytial virus infection in adults: Differences with influenza

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 62-68

2021

  1. Coordinated assistance plan for the elimination of hepatitis C virus at the centro de ayuda integral al drogodependiente (CAID (Comprehensive Care Centre for Drug Addicts))

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 3, pp. 214-220

2020

  1. Evaluation of compliance with the antibiotic prophylaxis protocol in hysterectomy. Prospective cohort study

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 3, pp. 180-186

2019

  1. Food poisoning caused by scombroids: A case-control study

    Journal of Infection and Public Health, Vol. 12, Núm. 4, pp. 591-593

  2. High delayed mortality after the first episode of Clostridium difficile infection

    Anaerobe, Vol. 57, pp. 93-98

  3. Probiotic Yogurt for the Prevention of Antibiotic-associated Diarrhea in Adults: A Randomized Double-blind Placebo-controlled Trial

    Journal of Clinical Gastroenterology, Vol. 53, Núm. 10, pp. 717-723

2018

  1. Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 393-398

  2. Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697

2017

  1. Assessment of antibiotic prophylaxis adequacy in rectal surgery

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 30, Núm. 1, pp. 14-18

  2. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

    Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8

  3. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

  4. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam

    Infection, Vol. 45, Núm. 1, pp. 115-117

  5. The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 2, pp. 295-303

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  2. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8

2015

  1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

    Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9

  2. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance

    Journal of Infection, Vol. 71, Núm. 3, pp. 385-394

  3. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10

  4. Health-care management of an unexpected case of Ebola virus disease at the Alcorcón Foundation University Teaching Hospital

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 4, pp. 228-232

2014

  1. Comparison of imported Plasmodium ovale curtisi and P. ovale wallikeri infections among patients in Spain, 2005-2011

    Emerging Infectious Diseases, Vol. 20, Núm. 3, pp. 409-416